Latest Headlines

Latest Headlines

Another Actos lawsuit reaches a jury for weary Takeda

Another jury in another U.S. trial over Takeda Pharmaceutical and its Actos (pioglitazone) diabetes drug has begun deliberating whether the drug was responsible for causing cancer. Lawyers for both sides completed closing arguments in the Pennsylvania trial.

Takeda back in court facing bladder cancer claims against Actos

Lawyers in another Actos failure-to-warn trial claimed the company put profits ahead of patient safety, by keeping mum on study data that flagged links between the diabetes drug and cancer.

Takeda and Lilly remain on the hook for $9B Actos award

Legal experts have insisted there is no way that a $9 billion punitive damage award against Takeda Pharmaceutical and Eli Lilly for hiding Actos risks can stand. But the two companies are still sweating that one out after a federal judge refused to throw out the verdict and its mammoth award on Thursday.

Database provides fresh evidence of effect of diabetes drugs on Alzheimer's

This week a German team presented data from a database analysis study that found a link between a diabetes drug and a slight dip in the risk of developing Alzheimer's.

Takeda now 5 for 6 in winning Actos cases, but that loss was a stunner

On Thursday, Takeda Pharmaceutical fended off a lawsuit by two women ages, 80 and 81, who wanted $1 billion in actual damages, claiming they suffered bladder cancer as a result of taking the company's diabetes drug Actos.

Jury's out in Las Vegas after 3-month trial over Actos cancer risks

In federal court in Las Vegas, a trial over the cancer risks of Takeda's Actos drug wrapped up Tuesday, leaving the jury to decide whether the diabetes remedy triggered the plaintiffs' disease--and if so, how much they should collect from the Japanese drugmaker.

Takeda wins another Actos verdict weeks after losing big in federal court

Just weeks after a federal jury in Louisiana gut-punched Takeda and Eli Lilly with a $9 billion verdict over diabetes drug Actos, an Illinois jury promptly let the company off the hook.

Jury slaps Takeda, Lilly with massive $9B in damages in Actos cancer case

A Louisiana jury pummeled Takeda Pharmaceutical and Eli Lilly & Co. with $9 billion in punitive damages in a liability suit over their blockbuster diabetes drug Actos. It's one for the record books, an amount so far beyond normal that even the victorious lawyers discounted it.

UPDATED: A key Actos trial revs up in Vegas with demands for a $1B-plus judgment

The latest trial over Actos' bladder-cancer risks is set to begin. With thousands of other Actos cases pending against Takeda, the case already was destined to be closely watched. And now, one of the plaintiff's lawyers says he's planning to seek the largest verdict in Nevada history.

Actos jury says Takeda failed at safety warnings, but judge tosses $1.7M verdict

The jury has spoken in the latest Actos trial, and the verdict was this: Takeda Pharmaceutical didn't properly flag the risks of its diabetes drug, and Takeda should pay $1.7 million to the family of Diep An, an Actos patient who died of bladder cancer.